Type of test Blood

Normal findings

 Cardiac troponin T: < 0.1 ng/Ml

 Cardiac troponin I: < 0.03 ng/mL

hsTnT :

 < 14 ng/L for women

< 22 ng/L for men

Test explanation and related physiology

 Cardiac troponins are important biochemical markers for cardiac disease. This test is used to assist in the evaluation of patients with suspected acute coronary ischemic syndromes. In addition to improving the diagnosis of acute ischemic disorders, troponins are also valuable for early risk stratification in patients with unstable angina. They can be used to predict the likelihood of future cardiac events. There are two cardiac-specific troponins: cTnT and cTnI.

Because of their extraordinarily high specificity for myocardial cell injury, cardiac troponins are very helpful in the evaluation of patients with chest pain. Their use is similar to that of creatine kinase-MB (CK-MB). However, cardiac troponins have several advantages over CK-MB. Cardiac troponins are more specific for cardiac muscle injury. CK-MB can be elevated in severe skeletal muscle injury, brain or lung injury, or renal failure. Cardiac troponins will nearly always be normal in noncardiac muscle diseases. Cardiac troponins become elevated sooner and remain elevated longer than CK-MB. This expands the time window of opportunity for diagnosis and thrombolytic treatment of myocardial injury. Finally, cTnT and cTnI are more sensitive to muscle injury than CK-MB. That is most important in evaluating patients with chest pain.

Cardiac troponins become elevated as early as 2 to 3 hours after myocardial injury. Typically, 2 to 3 sets of troponins over the course of a day (every 3-6 hours) are required to indicate myocardial infarction. Levels of cTnI may remain elevated for 7 to 10 days after myocardial infarction, and cTnT levels may remain elevated for up to 14 days. High sensitivity (hs)TnT rep resents an important advance with added sensitivity for cardiac myocyte necrosis. hsTnT assays detect concentrations of troponins at much lower concentrations, thereby detecting infarction earlier in the process (as early as 90 minutes). hsTnT speeds the triage of patients with suspected myocardial infarction.

Cardiac troponins are used in the following cardiac clinical situations:

• Evaluation of patient with unstable angina. If cardiac troponins are normal, no myocardial injury has occurred, and there will be no lasting cardiac dysfunction. If cardiac troponins are elevated, muscle injury has occurred. Revascularization may be indicated because this latter group is at great risk for a subsequent cardiac event (infarction or sudden death).

 • Detection of reperfusion associated with coronary recanalization. A washout, or second peak of cardiac troponin levels, accurately indicates reperfusion by way of recanalization or coronary angioplasty.

• Estimation of myocardial infarction size. Late (4 weeks) cardiac troponin levels are inversely related to left ventricular ejection fraction.

• Detection of perioperative myocardial infarction. Cardiac troponins are not affected by skeletal muscle injury.

• Evaluation of the severity of pulmonary emboli. Elevated levels may indicate more severe disease and the need for thrombolytic therapy.

 • Congestive heart failure. Persistently elevated troponins indicate continued ventricular strain.

Elevations of troponin T do not necessarily indicate the presence of an ischemic mechanism. Many other disease states are associated with elevations of troponin T via mechanisms different from those that cause injury in patients with acute coronary syndromes. These include cardiac trauma (e.g., contusion, ablation, or pacing), congestive heart failure, hypertension, hypotension (often with arrhythmias), pulmonary embolism, renal failure, and myocarditis. Interfering factors

 • Severe skeletal muscle injury may cause false elevation of cTnT.

 • Troponin T levels are falsely elevated in dialysis patients.

Procedure and patient care

 • See inside front cover for Routine Blood Testing.

• Fasting: no

• Blood tube commonly used: yellow

* Discuss with the patient the need and reason for frequent venipuncture in diagnosing myocardial infarction.

• After the initial blood sample, blood is collected 12 hours later followed by daily testing for 3 to 5 days and possibly weekly for 5 to 6 weeks.

 • Record the exact time and date of venipuncture on each laboratory slip. This aids in the interpretation of the temporal pat tern of enzyme elevations.

• If a qualitative immunoassay is to be done at the bedside, whole blood is obtained in a micropipette and placed in the sample well of the testing device. A red or purple color in the read zone indicates that 0.2 ng/mL or more of cardiac troponin is present in the patient’s blood.

Abnormal findings

Increased levels

- Myocardial injury

- Myocardial infarction

اخر الاخبار

اخبار العتبة العباسية المقدسة

قسم شؤون المعارف يطلق دورة (صفات الشيعة) لعدد من ملاكات العتبة العباسية المقدسة

الهيأة العليا لإحياء التراث تبحث تعزيز التعاون المشترك مع مركز الإمام الباقر (عليه السلام) في إيران

جامعة الكفيل تكرِّم طلبتها المتميزين من ذوي الاحتياجات الخاصة

فريق طبي في مستشفى الكفيل يجري عملية ناجحة لطفل يعاني من تشوّه ولاديّ بالنخاع الشوكي

المزيد

الآخبار الصحية

خصوصا مع تقدم السن.. 6 سلوكيات يومية قد تدمّر صحتك

فاكهة خضراء.. علاج طبيعي فعّال للإمساك واضطرابات الهضم

روسيا تبدأ أولى التجارب السريرية للقاح واعد ضد السرطان

كنز غذائي على طبقك.. ماذا تفعل السبانخ بجسمك؟

المزيد

الآخبار التكنلوجية

رصد نوع نادر من القطط في تايلاند للمرة الأولى منذ عقود

روسيا تخطط لإقامة محطة نووية في القمر خلال العقد المقبل

كيف قاد إيلون ماسك حملة "غروك" لاختراق عرش الذكاء الاصطناعي

ألتمان: الذكاء الاصطناعي سيتجاوز البشر في 2026 !

المزيد

مواضيع ذات صلة

marijuana (THC) test (Cannabinoid or cannabis testing, Tetrahydrocannabinol [THC] testing)

lung cancer molecular testing (AKT1, ALK, BRAF, Epidermal growth factor [EGFR], HER2, KRAS, MEK1, MET, NRAS, PIK3CA, RET, and ROS1)

kidney stone analysis (Urinary stone analysis, Renal calculus analysis)

Variability and Standardization of CSF Examination

Lab Diagnosis of Yellow fever

hexosaminidase (Hexosaminidase A, Hex A, Total hexosaminidase, Hexosaminidase A and B)

hemoglobin electrophoresis (Hgb electrophoresis)

growth hormone stimulation test (GH provocation test, Insulin tolerance test [ITT], Arginine test, Glucagon Stimulation test)

Markers of Bone Resorption: Amino and Carboxy-Terminal Telopeptides of Collagen Type I

Markers of Bone Resorption: Collagen Cross-Links

Bone Formation Markers : Osteocalcin

Diagnosis of Prion Disease